About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Breast Cancer Clinical Trials | 16,764 Studies Recruiting

Clinical TrialsBreast Cancer

Breast Cancer Clinical Trials

Browse 16,764 clinical trials for breast cancer. Find studies that match your criteria and connect with research centers.

Find trials near:

New York Los Angeles Chicago Houston Phoenix Philadelphia

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 6341-6360 of 16,764 trials

Active not recruitingClinical Pilot Study for Personalized Risk-based Breast Cancer ScreeningThe study aims to evaluate the impact of implementing population-based genetics testing strategy for breast cancer precision prevention using the polygenic risk score and…NCT05731453·Drammen CompletedPredicting Response to Capecitabine in Women With Metastatic Breast CancerRATIONALE: Identifying genes that increase a person's susceptibility to side effects caused by capecitabine may help doctors plan better treatment.NCT00953537·Nice CompletedBRCA and NACT in TNBC PatientsThe goal of this observational study is to evaluate data from patients with triple-negative breast cancer (TNBC) treated with neoadjuvant chemotherapy (NACT) in order to better…NCT05750719·Rome, RM CompletedMetabolomics and Breast Cancer Risk in a Nested Case-control Study of the Cancer Prevention Study-II Nutrition CohortThis study aims to investigate diet, lifestyles, serum metabolomics in relation to breast cancer risk in a nested case-control study including 1,547 postmenopausal women from the…NCT03282812

Related Searches

breast carcinomatrials

Data from ClinicalTrials.govTerms

UnknownDiagnostic Power Comparison Between VOCs and CTCsEarly diagnosis of malignant tumors is pivotal for improving their prognoses.NCT03958812

CompletedA Study to Determine the Safety and Tolerability of Herceptin as an Adjuvant Therapy of Early Breast CancerThis was an open-labeled, multi-center, prospective, non-comparative study of the safety of Herceptin (trastuzumab) used as an adjuvant therapy in patients with early breast…NCT02443467·Kamenitz

Not yet recruitingAbemaciclib for Molecular Residual Disease Detected by Circulating Tumor DNA in HR+/HER2- Early Breast CancerThe goal of this clinical study is to determine whether monitoring ctDNA and treating patients who become ctDNA-positive with abemaciclib can help prevent the recurrence of…NCT07292207·Nagoya

CompletedStudy of ASLAN001 in Combination With Capecitabine in MBC That Has Failed on Prior TrastuzumabThis is an open-label, randomized, parallel group Phase 2A/2B study to evaluate the clinical activity of ASLAN001 in combination with capecitabine compared with lapatinib in…NCT02338245·Western Australia and 18 others

TerminatedTrial of Paclitaxel, Bevacizumab, and Enzastaurin Versus Paclitaxel, Bevacizumab and Placebo for Breast CancerThe purpose of this study is to determine efficacy and safety of paclitaxel, bevacizumab and enzastaurin versus paclitaxel, bevacizumab, and placebo in participants who are…NCT00536939·Newark, Delaware and 6 others

CompletedReducing Breast Cancer Recurrence With Weight LossThe purpose of the ENERGY trial is to explore whether two different programs that are focused on weight management, through increased exercise and a healthy diet, are feasible…NCT01112839·Birmingham, Alabama and 3 others

UnknownEfficacy and Safety of Wuling San on Breast Cancer-related LymphedemaThe purpose of this study is to assess the efficacy and safety of Wuling San, a traditional Chinese medicine, in reducing arm volume excess in women with stage I-II breast cancer…NCT02726477·Liuzhou, Guangxi and 2 others

Active not recruitingAbraxane® With or Without Mifepristone for Advanced, Glucocorticoid Receptor-Positive, Triple-Negative Breast CancerThis is a randomized, placebo-controlled, double-blind, phase II trial of nab-paclitaxel with or without mifepristone for advanced, glucocorticoid receptor-positive…NCT02788981·Birmingham, Alabama and 4 others

TerminatedPotential Biomarkers for Bevacizumab-Induced High Blood Pressure in Patients With Solid TumorRATIONALE: Studying samples of blood and urine in the laboratory from patients with cancer receiving bevacizumab may help doctors learn more about changes that occur in DNA and…NCT01096381·Nashville, Tennessee and 1 other

Active not recruitingSHORTened Duration of TAMoxifenThe purpose of this study is to learn whether a shorter-duration, low-dose tamoxifen regimen can reduce the risk of developing breast cancer or breast cancer recurrence in…NCT07806630·New Brunswick, New Jersey

CompletedTrial of Neoadjuvant EndoTAG-1 in Combination With Paclitaxel in HER2-negative Breast CancerThe study hypothesis is that the new drug EndoTAG-1 will improve tumor volume reduction as measured by Magnetic Resonance Imaging when added to a standard chemotherapy regimen of…NCT01537536·Brussels, Brussels Capital

Not yet recruitingEvaluation of the RESTART Survival ProgrammeThe RESTART survivorship programme has been implemented in the care pathway for patients with localised breast cancer since 2022.NCT06283511

RecruitingA Prospective, Phase II Trial Using ctDNA to Initiate Post-operation Boost Therapy After Adjuvant Chemotherapy in TNBCCirculating tumor DNA (ctDNA) has been demonstrated to be an effective prognostic marker in breast cancer.NCT04803539·Guandong, Guangdong

CompletedA PK Study Testing Single Oral Dose of Elacestrant in Subjects With Normal or Severely Impaired Hepatic FunctionThis is a Phase 1, multi-center, open-label, non-randomized, parallel group study to evaluate the effect of severe hepatic impairment on the PK, safety and tolerability of a…NCT06126575·Yucaipa, California and 2 others

UnknownA Feasibility Study of the Bone@BC App Version 3.0Introduction Due to improvements in diagnostics and treatments, the 5-year survival for patients with breast cancer is 80-90% after initial diagnosis.NCT05367830

CompletedProspective Radiologic Evaluation of Changes Following Fat GraftingBreast implants are currently used for cosmetic breast augmentation and in breast reconstruction following mastectomy for breast cancer.NCT01343030·Minneapolis, Minnesota and 1 other

PreviousPage 318 of 839Next